CPhI Announces Exhibitors' Latest Product News and Awards Finalists Ahead of Show

Amsterdam (ots/PRNewswire) -

Novel nanonization technology enhances API solubility

Chris Kilbee - Group Director Pharma, commenting on the
announcements: "The new products and award finalists are showcasing
some remarkable technologies that are driving innovation across the
pharma sector and developing tomorrow's drugs today."

CPhI Pharma Award Finalists

Best Innovation in Process Development

- API Corporation: A novel and practical synthesis of highly functionalized
pharmaceuticals through C-H activation
- Bachem: Pioneering breakthrough in the chemical synthesis of Interferon
beta-1a
- Codexis: Enzymes for Green and Scalable Biocatalytic Oxidations

Best Innovation in Formulation

- Bitop: Ectoin(R) - a new natural ingredient with proven efficacy
- Camurus: FluidCrystal(R) Injection depot
- EmulTech: Microfluidic platform for controlled development

Best Innovation in Packaging

- E-Pharma Trento: E-PHARMA TRENTO SpA
- Doctor Pack India: MAGIC CAP
- Neutroplast: Vaginal applicator

CPhI has today released its CPhI Pharma Awards finalists and some
of the new product announcements of its exhibitors ahead of CPhI
Worldwide [http://www.cphi.com ] 2013- featuring products and
services ranging from nanonization of APIs to sterile
water-for-injection solutions. The product announcement comes prior
to the conference in Frankfurt , allowing attendees to maximise on
the latest innovations seen across the pharmaceutical industry before
the show. Additionally, you will also be able to hear from the awards
finalists during their individual sessions at the Speaker's Corners
[http://www.cphi.com/europe/networking/cphi-speakers-corner ].

(Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

Blank canvas offered at CPhI

In contrast to CMOs traditionally offering fixed equipment
capabilities, SCM Pharma will be attending CPhI to offer
pharmaceutical companies the opportunity to design their clinical and
contract manufacturing projects from a 'blank' canvas. The CMO, which
specialises in the sterile manufacturing of drug products, is
offering cleanroom space at their new 26k sq. ft. site, allowing
customers to design their own projects based on their specific
manufacturing requirements. SCM Pharma's new site houses cutting-edge
technology for aseptic processing and terminal sterilisation
capabilities, which will facilitate the handling of highly potent,
flammable and toxic products, along with controlled drugs. With space
for late stage and commercial scale projects, the CPhI exhibitor is
able to work alongside companies with more complex needs in
developing novel processes within, for example, unusual drug dosage
forms and smaller fill volumes.

API technology solves solubility issues

As a key formulations issue, poor API solubility has proved to be
a significant challenge within the pharmaceutical industry. However,
NETZSCH will be present at CPhI Worldwide, providing the latest
solution with their agitator bead mill DeltaVita(R). The DeltaVita(R)
features a range of models, from small laboratory- to production-size
machines, all having been specially designed to effectively enhance
API solubility and, in turn, improve efficacy. By enabling users to
consistently generate particle sizes of below 100 nanometers, the
technology results in APIs with increased surface area, solubility
and bioavailability. Nanonization provides distinguished advantages
including a more targeted delivery of genes and vaccines. The
increased bioavailability also means that the amount of API required
will be sufficiently reduced, bearing multiple advantages including
cost-efficiency, reduced risk and fewer side effects of the finished
product. Attendees at CPhI Worldwide will be able to visit NETZSCH to
discover the DeltaVita(R) series which provides an advanced, scalable
and reproducible product offering.

Vetter extends filling capabilities backed by five years of data

Further, supported by five years of stability data, Vetter will be
showcasing their sterile water-for-injection (sWFI) solution. The
CDMO has collated substantial data and adopted a bracketing concept
to offer a filling service for high-quality sWFI syringes, creating a
longer shelf life for drugs, and providing high flexibility when
defining the required filling volume.

Drugs are often lyophilized in order to reduce sensitivity to
environmental factors - this process ensures that drugs maintain a
longer shelf life. However, the drug must be returned to its original
state by being dissolved in a solvent to allow for treatment to a
patient and it is Vetter's unparalleled solution that facilitates
safe and simple handling of this process. The intelligent filling
system is able to load the exact amount of solvent required by a
customer, to generate the correct dosage. Further benefiting
customers, Vetter's syringes are fully equipped with effective
protection features, including a tamper-evident closure, to provide
ultimate product security. The company has the capability to
manufacture batches of up to 120,000 / 140,000 pieces and is ICH
compliant - with documentation already existing for the USA, Europe
and Japan for customers looking to break into international markets.

"An ever greater number of manufacturers are looking for options
to enable a safe and simple administration of lyophilized drugs. Our
filling service for WFI syringes represents a reliable and
patient-friendly solution offering our customers high flexibility due
to Vetter's bracketing concept, and fast time-to-market by using the
ready-to-submit documents. In addition to documents for approval in
the USA and Europe, we also have all the necessary documentation for
Japan available for pharmaceutical and biotech firms, which can
considerably abridge the approval process." - Peter Soelkner,
Managing Director of Vetter.

Grga & Melita offering hi-spec laboratory furniture solutions

Croatian-based company Grga & Melita will be bringing 20 years of
experience in producing high-spec laboratory furniture to CPhI. Their
latest GIM lab laboratory furniture has been manufactured in
accordance with the highest European standards by a team of
experienced designers and lab specialists.

Grga & Melita offer tailor made solutions for products including
fume hoods, laboratory sinks and work benches, whilst also offering a
wife range of safety cabinets for storage of acids, lyses, poisons,
flammables and compressed gas cylinders. By providing unique
construction solutions and an individual approach, the GIM lab
laboratory furniture is distinctive within the market.

CPhI is hosting the latest products and services offered by
companies across the pharmaceutical industry from 22 - 24 October
with further exhibitors announcing their latest news and innovations
at the press conference taking place across the entire three days.

Chris Kilbee - Group Director Pharma, commenting on the
announcements: "We are delighted to share the latest services on
offer from exhibiting companies at CPhI Worldwide. We have witnessed
an array of novel products, clearly showcasing the extensive and
committed innovations across the pharmaceutical sector. By providing
this platform, we have given the industry the opportunity to see what
is on offer ahead of the show to allow them to further maximise their
time at the event."

Notes to editors

About CPhI

CPhI drives growth and innovation at every step of the global
pharmaceutical supply chain from drug discovery to finished dosage.
Through exhibitions, conferences and online communities, CPhI brings
together more than 100,000 pharmaceutical professionals each year to
network, identify business opportunities and expand the global
market. CPhI hosts events in Europe, China, India, Japan, Southeast
Asia, Russia and South America co-located with ICSE for contract
services, P-MEC for machinery, equipment & technology, InnoPack for
pharmaceutical packaging and BioPh for biopharma. CPhI provides an
online buyer & supplier directory at CPhI-Online.com and hosts a
global community with news and analysis at PharmaEvolution.com.

For more information visit: http://www.cphi.com

The UBM Live annual schedule of Pharmaceutical events also
includes CPhI Worldwide, ICSE, P-MEC Europe and InnoPack ; CPhI and
P-MEC India (3-5 December, 2013 at the Bombay Exhibition Centre in
Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan ; CPhI Russia
and IPhEB (16-17 April, 2014 in St Petersburg, Russia); CPhI, P-MEC
and Innopack South East Asia (20-22 May, 2014 in Jakarta, Indonesia);
CPhI Istanbul (4-6 June, 2014, Turkey) and CPhI, Hi and Fi, ICSE,
P-MEC, BioPh and LabWorld China (26-28 June, 2014 at SNIEC, Shanghai,
China).

About UBM Live

UBM Live connects people and creates opportunities for companies
across five continents to develop new business, meet customers,
launch new products, promote their brands, and expand their market.
Through premier brands such as TFM&A, Internet World, IFSEC, MD&M,
CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM
Live exhibitions, conferences, awards programs, publications,
Websites, and training and certification programs are an integral
part of the marketing plans of companies across more than 20 industry
sectors.

For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44(0)207-203-6745 / 6740
E: a.heeley@defacto.com / t.jervis@defacto.com

Photo:
http://photos.prnewswire.com/prnh/20130723/629764-a

ots Originaltext: UBM Live
Im Internet recherchierbar: http://www.presseportal.de